BRPI0918536A2 - sal de derivado de morfolina - Google Patents

sal de derivado de morfolina

Info

Publication number
BRPI0918536A2
BRPI0918536A2 BRPI0918536A BRPI0918536A BRPI0918536A2 BR PI0918536 A2 BRPI0918536 A2 BR PI0918536A2 BR PI0918536 A BRPI0918536 A BR PI0918536A BR PI0918536 A BRPI0918536 A BR PI0918536A BR PI0918536 A2 BRPI0918536 A2 BR PI0918536A2
Authority
BR
Brazil
Prior art keywords
morpholine derivative
derivative salt
salt
morpholine
derivative
Prior art date
Application number
BRPI0918536A
Other languages
English (en)
Inventor
Akio Kuroda
Kazuhiro Takeguchi
Kazumi Kikuchi
Kenichirou Sakamoto
Ryo Mizoguchi
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of BRPI0918536A2 publication Critical patent/BRPI0918536A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BRPI0918536A 2008-09-11 2009-09-10 sal de derivado de morfolina BRPI0918536A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008234066 2008-09-11
PCT/JP2009/065792 WO2010029959A1 (ja) 2008-09-11 2009-09-10 モルホリン誘導体の新規な塩

Publications (1)

Publication Number Publication Date
BRPI0918536A2 true BRPI0918536A2 (pt) 2015-09-22

Family

ID=42005211

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918536A BRPI0918536A2 (pt) 2008-09-11 2009-09-10 sal de derivado de morfolina

Country Status (13)

Country Link
US (1) US20110166348A1 (pt)
EP (1) EP2330099A4 (pt)
JP (1) JPWO2010029959A1 (pt)
KR (1) KR20110057214A (pt)
CN (1) CN102149699A (pt)
AU (1) AU2009292499A1 (pt)
BR (1) BRPI0918536A2 (pt)
CA (1) CA2736560A1 (pt)
MX (1) MX2011002728A (pt)
RU (1) RU2011113720A (pt)
TW (1) TW201022219A (pt)
WO (1) WO2010029959A1 (pt)
ZA (1) ZA201101583B (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109088A (en) 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
JPS6039671B2 (ja) * 1976-10-27 1985-09-06 山之内製薬株式会社 ２−（７−インデニルオキシメチル）モルホリンの酸付加塩の製法
TW200846002A (en) 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy

Also Published As

Publication number Publication date
WO2010029959A1 (ja) 2010-03-18
CA2736560A1 (en) 2010-03-18
TW201022219A (en) 2010-06-16
CN102149699A (zh) 2011-08-10
JPWO2010029959A1 (ja) 2012-02-02
RU2011113720A (ru) 2012-10-20
MX2011002728A (es) 2011-04-21
KR20110057214A (ko) 2011-05-31
AU2009292499A1 (en) 2010-03-18
ZA201101583B (en) 2012-06-27
US20110166348A1 (en) 2011-07-07
EP2330099A1 (en) 2011-06-08
EP2330099A4 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
FR24C1047I2 (fr) Derive de 4-pyrimidinesulfamide
EP2098517A4 (en) NEW PHENYLISOXAZOLE-3-OLDERIVATE
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
EP2226315A4 (en) 2-aminoquinazoline DERIVATIVE
BRPI0816278A2 (pt) forma sal
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0807004A2 (pt) Sal
EP2336132A4 (en) MORPHOLINPURINDERIVAT
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
EP2433940A4 (en) SPIROIMIDAZOLONDERIVAT
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
EP2397480A4 (en) DIAZEPINEDIONEDERIVATE
DK2275414T3 (da) Cyclopentylacrylamidderivat
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0922652A2 (pt) Derivados de quinazolinamida
EP2401281A4 (en) PYRIMIDINPYRIMIDOINDAZOLDERIVAT
EP2168952A4 (en) morpholine

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.